OBJECTIVE: To compare microbial translocation and its biomarkers in HIV-1-infected African and White patients of the Liège AIDS Reference Center. DESIGN: The study is based on a cross-sectional dataset of HIV-infected patients treated at the Liège AIDS Reference Center. Groups of white and African patients have been randomly selected to be identical for sex, age and duration of treatment. METHODS: sCD14, lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP) and routine HIV-follow-up parameters were measured on plasma samples. RESULTS: High values of LPS and LBP were observed in both groups of patients without significant difference between them. High values of sCD14 were observed in 53.1% of whites and only in 18.8% of African patients (P = 0.0042). A correlation between LPS and sCD14 was observed in whites but not African patients. CONCLUSION: Our observation suggests that factors not related to microbial translocation are responsible for lower sCD14 value in Africans.
OBJECTIVE: To compare microbial translocation and its biomarkers in HIV-1-infected African and White patients of the Liège AIDS Reference Center. DESIGN: The study is based on a cross-sectional dataset of HIV-infectedpatients treated at the Liège AIDS Reference Center. Groups of white and African patients have been randomly selected to be identical for sex, age and duration of treatment. METHODS: sCD14, lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP) and routine HIV-follow-up parameters were measured on plasma samples. RESULTS: High values of LPS and LBP were observed in both groups of patients without significant difference between them. High values of sCD14 were observed in 53.1% of whites and only in 18.8% of African patients (P = 0.0042). A correlation between LPS and sCD14 was observed in whites but not African patients. CONCLUSION: Our observation suggests that factors not related to microbial translocation are responsible for lower sCD14 value in Africans.
Authors: Michael Reid; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Audrey L French; Michael W Plankey; Carl Grunfeld; Phyllis C Tien Journal: AIDS Date: 2017-01-28 Impact factor: 4.177
Authors: Jessica Robinson-Papp; Alexandra Nmashie; Elizabeth Pedowitz; Emma K T Benn; Mary Catherine George; Sandeep Sharma; Jacinta Murray; Josef Machac; Sherif Heiba; Saurabh Mehandru; Seunghee Kim-Schulze; Allison Navis; Isabel Elicer; Susan Morgello Journal: AIDS Date: 2018-06-01 Impact factor: 4.177
Authors: Jessica Robinson-Papp; Alexandra Nmashie; Elizabeth Pedowitz; Mary Catherine George; Sandeep Sharma; Jacinta Murray; Emma K T Benn; Steven A Lawrence; Josef Machac; Sherif Heiba; Seunghee Kim-Schulze; Allison Navis; Bani Chander Roland; Susan Morgello Journal: J Neurovirol Date: 2019-05-16 Impact factor: 2.643
Authors: Adriana Weinberg; Mark J Giganti; Patricia A Sirois; Grace Montepiedra; Jennifer Canniff; Allison Agwu; Michael J Boivin; Suad Kapetanovic; Mark J Abzug Journal: AIDS Date: 2022-04-19 Impact factor: 4.632
Authors: Suad Kapetanovic; Mark J Giganti; Mark J Abzug; Jane C Lindsey; Patricia A Sirois; Grace Montepiedra; Jennifer Canniff; Allison Agwu; Michael J Boivin; Adriana Weinberg Journal: AIDS Date: 2021-07-15 Impact factor: 4.632
Authors: Carol L Vinton; Carly E Starke; Alexandra M Ortiz; Stephen H Lai; Jacob K Flynn; Ornella Sortino; Kenneth Knox; Irini Sereti; Jason M Brenchley Journal: Pathog Immun Date: 2020-04-24
Authors: Edith M Walker; Nadia Slisarenko; Giovanni L Gerrets; Brooke F Grasperge; Julie A Mattison; Patricia J Kissinger; David A Welsh; Ronald S Veazey; S Michal Jazwinski; Namita Rout Journal: Front Immunol Date: 2021-02-25 Impact factor: 7.561